GL
BIVV

GLG LLC’s Bioverativ Inc. Common Stock BIVV Stock Holding History

GLG LLC’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$480K Hold
8,909
– – 0.03% 353
2017
Q3 		$508K Sell
8,909
-828
-9% -$48.5K 0.03% 385
2017
Q2 		$586K Sell
9,737
-1,132
-10% -$64.5K 0.04% 390
2017
Q1 		$592K Buy
+10,869
New +$535K 0.03% 419

Other funds holding BIVV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

GLG LLC's BIVV Position: Q4 2017 in Review

GLG LLC held its Bioverativ Inc. Common Stock (BIVV) position steady in Q4 2017 at 8,909 shares worth $480K. The position accounts for 0.03% of the portfolio, ranked #353.

GLG LLC first reported a position in BIVV in Q1 2017 and has held it in 4 quarters since. The position peaked at $592K in Q1 2017. 459 funds tracked by Wall St. Rank hold BIVV as of Q4 2017.

  • GLG LLC held 8,909 shares of Bioverativ Inc. Common Stock worth $480K as of Q4 2017.
  • GLG LLC left its Bioverativ Inc. Common Stock share count unchanged in Q4 2017.
  • Bioverativ Inc. Common Stock made up 0.03% of GLG LLC's portfolio in Q4 2017, its #353 holding.
  • GLG LLC first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and has held it in 4 quarters since.
  • GLG LLC's Bioverativ Inc. Common Stock position peaked at $592K in Q1 2017.
  • 459 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q4 2017.

Based on GLG LLC's 13F filing for Q4 2017, filed 14 Feb 2018.